KUALA LUMPUR, Nov 3 (Bernama) -- Fortrea, a global contract research organisation (CRO), has completed a multi-year effort to expand its clinical pharmacology solutions and capacity, which are now fully available for customers.
The expansion includes a 100,000 square feet state-of-the-art facility in Leeds, the United Kingdom as well as approximately 20,000 square feet of new or renovated space, adding capacity and capabilities across its clinical research units (CRUs) in Dallas, Texas; Daytona, Florida; and Madison, Wisconsin.
“Our integrated platform of services includes best-in-class infrastructure and experienced professionals who are fully dedicated to clinical pharmacology, including physicians, nurses, clinical scientists, CRAs and pharmacokineticists.
“The investments we have made target the capabilities and capacity that customers need to accurately assess early pipeline candidates and speed those with promise to later-phase development and ultimately to patients who need them,” said Fortrea president of Clinical Pharmacology and chief medical officer, Dr Oren Cohen.
Facility enhancements following the completed expansion include Fortrea’s new CRU in Leeds as well as purpose-built rooms in Madison and Daytona designed for flexibility in executing complex early phase clinical studies.
According to Fortrea in a statement, improvements in recreational, living and “work-from-home” spaces at Fortrea CRUs have been constructed to enhance the experience of volunteers participating in research at the sites.
Meanwhile, the expansion of Fortrea’s early clinical development pharmacy services facilities includes new state-of-the-art current Good Manufacturing Practice (cGMP) pharmacies in the Leeds and Daytona CRUs, in which all Fortrea CRUs will now have cGMP pharmacies within them.
Enhancements in science and technology include the addition of artificial intelligence-enabled programmes that optimise bed space utilisation and clinic scheduling, and the application of failure modes and effects analysis to de-risk study execution before a study begins.
Following investments in data collection systems, all clinical pharmacology study data collected within Fortrea CRUs are input directly into a digital bedside data capture system, which can also be used as an efficient electronic data capture solution.
-- BERNAMA
No comments:
Post a Comment